Clinical laboratory experience of blood CRIM testing in infantile Pompe disease

Cross-reactive immunological material (CRIM) status is an important prognostic factor in patients with infantile Pompe disease (IPD) being treated with enzyme replacement therapy. Western blot analysis of cultured skin fibroblast lysates has been the gold standard for determining CRIM status. Here,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Genet Metab Rep
Auteurs principaux: Bali, Deeksha S., Goldstein, Jennifer L., Rehder, Catherine, Kazi, Zoheb B., Berrier, Kathryn L., Dai, Jian, Kishnani, Priya S.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2015
Sujets:
Short Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674832/
https://ncbi.nlm.nih.gov/pubmed/26693141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgmr.2015.10.012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires